However, safety and efficacy data in pregnancy remain limited.<h4>Methods</h4>A systematic review analyzed 8 clinical trials from ClinicalTrials.gov examining the use of GLP-1 liraglutide, semaglutide, and exenatide in GDM treatment. This evidence concerns the gene GLP1R and gestational diabetes.